When a buyer in one country wants to register a medicine made in another, the importing regulator asks a single question first: is this product actually authorised to be sold where it was made? The Certificate of Pharmaceutical Product — the CPP — is the exporting country's formal answer to that question.
It is not a sales document, a quality certificate or a batch record. It is a statement by one national authority about the registration status of a product, addressed to another. That one distinction explains most of the confusion around CPPs.
What a CPP actually is
The CPP is defined by the World Health Organization's certification scheme, which most countries follow in substance even when they use their own form. Its purpose is narrow and precise: to tell the importing country whether a product is authorised for marketing in the exporting country, and to summarise what that authorisation covers.
A CPP does not certify quality for a specific shipment. It does not transfer an approval from one country to another. It is evidence a registration exists, nothing more and nothing less.
| A CPP proves | A CPP does not prove |
|---|---|
| The product is authorised for sale in the exporting country | That a specific batch is safe or of good quality |
| The marketing authorisation holder and the manufacturer | That the exporter has the holder's permission to export |
| The product name, strength and dosage form on file | That the product meets the importing country's own standards |
| The current marketing status (marketed, not marketed, withdrawn) | That the goods will ship, clear customs, or arrive intact |
Who issues it, and who can ask for it
The CPP is issued by the exporting country's drug regulator. In China that is the NMPA — in practice often through the provincial medical products administration that holds the registration file.
The important constraint is who can obtain one. The CPP is issued to the marketing authorisation holder, the legal entity that owns the registration — not to a trader, a broker, or an export agent. That is why the export chain matters: an exporter who is not the holder must be formally authorised by the holder before a CPP can be routed to the importing authority. This authorisation is what we mean by an export mandate.
The Chinese CPP vs the WHO-format certificate
China issues its own certificate of pharmaceutical product under NMPA rules. It carries the same essential information as the WHO format — product name, strength, dosage form, holder, manufacturer, marketing status — but the layout and some fields differ.
This creates a recurring friction point in export files:
| Dimension | Chinese CPP (NMPA) | WHO-format CPP |
|---|---|---|
| Issuer | NMPA / provincial MPA | National regulator, on the WHO template |
| Core fields | Same in substance (product, holder, manufacturer, status) | Same in substance |
| Layout | NMPA's own certificate format | Standardised WHO form |
| GMP statement | May be stated separately | Can include a GMP-compliance field |
| Who requests it | Holder, or an authorised exporter on the holder's behalf | Holder or exporter, per country rules |
Many importing authorities accept the Chinese certificate as equivalent when it contains the same information. A minority explicitly ask for a WHO-format CPP. In those cases the holder must confirm the product meets WHO standards and arrange the certificate accordingly — a distinction that should be settled before the licence application is lodged, not after it is rejected.
What to check on a CPP before you rely on it
- The holder matches the registration. The name on the CPP must be the entity that owns the approval number, not an unrelated trading company.
- The product matches your specification. Name, strength and dosage form must line up exactly with what you are buying — a CPP for a neighbouring strength does not cover your SKU.
- The status is current. "Marketed" versus "withdrawn" changes everything. Confirm the status field, not just that a certificate exists.
- The issuing authority is identifiable. A CPP should come with a seal and a reference you can verify against the regulator's record.
A CPP is one link in a chain of documents, not a stand-in for the whole chain. It answers "is this registered?" — the batch release certificate, the GMP evidence and the export mandate answer the other questions.
How a CPP fits the wider export file
For a plasma-derived product moving out of China, the CPP sits alongside several other documents, each answering a different question:
- The supplier document set — who the company is and what the product is.
- The batch release certificate — that the specific lot was released by the state.
- The export mandate — that the holder has authorised this exporter.
- The importing country's own licence application — where the CPP is actually submitted.
One caution specific to blood products: several countries restrict or prohibit the import of plasma-derived products regardless of registration. A CPP will not overcome a market that is closed by policy. If you are unsure whether your market can import a given product, that question should be answered before any certificate is ordered — it is the cheapest question to settle early.
Frequently asked questions
What exactly is a CPP?
A Certificate of Pharmaceutical Product is a document issued by the exporting country's drug regulator that confirms a product is authorised for sale in that country and states its marketing status. Importing countries use it to decide whether to register the product locally.
Who issues a CPP in China?
The NMPA, usually through its provincial counterparts, issues the Chinese equivalent. It is issued to the marketing authorisation holder, not to a trader, so an exporter must be authorised by the holder to obtain one.
Is a Chinese CPP the same as a WHO-format certificate?
Functionally yes, but the format and fields differ. The Chinese certificate follows the NMPA's own template. Many importing authorities accept it if it carries the equivalent information; some specifically request a WHO-format CPP, in which case the holder must confirm the product meets WHO standards.
How long does a CPP take to obtain from China?
Typically a few weeks once the holder submits the application and fees. The CPP is not the slow part of an export — the slow parts are usually the holder's authorisation chain and the importing country's own review.
Does a CPP guarantee the product can be exported?
No. A CPP confirms registration and marketing status in China. Export is a separate question of export authorisation, the holder's export mandate, and the importing country's rules — including whether plasma-derived products are even importable there.
Where to go next
- Documents a plasma supplier must provide — the full file, grouped by the question each document answers.
- How to verify a Chinese drug approval number — the check that underlies any CPP.
- Product index — registration references by product and manufacturer.